Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer
Introduction
Colorectal cancer is one of the most common cancers in western countries. Although the incidence and mortality are decreasing in many countries [1], [2], [3], colorectal cancer is a serious disease, and on average only 50% are alive 5 years after diagnosis [1], [2], [3]. It is estimated that worldwide there are about 400,000 deaths from colorectal cancer annually [1], [2], [3].
Dukes’ stage is one of the most important predictors of long-term outcome. In Denmark the expected 5-year survival for Dukes’ stage A is about 95%, for Dukes’ stage B is 50%, for Dukes’ stage C is 25%, and for Dukes’ stage D is 0%. At the time of diagnosis, 15% of all colorectal cancer patients are at Dukes’ stage A, 30% are at Dukes’ stage B, 35% are at Dukes’ stage C, and 20% are at Dukes’ stage D [4].
There is increasing evidence that screening for colorectal cancer can result in longer survival due to early detection at a non-advanced Dukes’ stage [5]. Thus, it is likely that we could improve prognosis and increase survival if more patients were to be diagnosed in Dukes’ stage A or B. However, for symptomatic patients, many aspects of the association between delay of treatment (interval between onset of symptoms and surgery or other treatment) and stage are poorly understood.
It has been suggested that delay of treatment may be a predictor of the stage of colorectal cancer; this idea, however, is controversial [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24]. Several studies have indicated no association between diagnostic delay or delay of treatment and stage of colorectal cancer at the time of diagnosis [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [23]. However, five studies found delay of treatment associated with the stage of cancer for rectal cancer [18], [19], [20], [21], [22], and three of them found delay of treatment associated with stage for colon cancer, as well [20], [21], [22].
Relatively few patients were included in the existing prospectively obtained studies (between 100 and 554 colorectal cancer patients). Most studies were based on delay data obtained solely from medical records [8], [12], [13], [14], [15], [16], [20], [25]. In some studies, rectal cancer and colon cancer were combined in the analysis [6], [8], [9], [10], [11], [14], [15], [17], [23], [24]. Other studies included either rectal cancer patients [12], [19] or colon cancer patients [13], [16], but not both.
The aim of this study was to examine the association between delay of treatment and stage of cancer at time of operation for colorectal cancer, based on prospectively recorded data in a population-based setting.
Section snippets
Study population and period
From 1 January 2001 to 30 June 2002, we conducted this prospective observational study in all the13 hospitals treating colorectal cancer, located in three counties in Denmark: Aarhus County (6 hospitals and about 630,000 inhabitants), and Ringkoebing and Ribe counties (7 hospitals and 475,000 inhabitants). Denmark has a tax-supported public health system for free hospital care in which private hospitals treat very few patients. More than 95% of Danes are registered with their own general
Descriptive data
Table 1 shows descriptive data of the 456 included colon cancer patients and the 277 included rectal cancer patients. The distribution of main variables was equal between all patients and included patients (data not shown).
Delay
The median delay for colon cancer patients was a little shorter than for rectal cancer patients (116 days versus 134 days). Table 2 shows data of delay of treatment. More colon cancer patients than rectal cancer patients had a short delay (27% versus 18%). Among colon cancer
Discussion
In this large population-based study, we found delay of treatment strongly associated with the risk of having an advanced cancer at time of operation for rectal cancer, but not for colon cancer.
To the best of our knowledge, this study has the largest number of prospective, registered colorectal cancer patients concerning delay in a population-based setting. The main strengths of our study are its large size, the uniformly organized free and tax-supported health care system with primary
Acknowledgements
Contributors include: Aarhus University Hospital—Consultants: Søren Laurberg, Marianne Korsgaard MD, Professor Henrik Toft Sørensen, Chief Biostatistician Lars Pedersen, Department of Clinical Epidemiology, Esbjerg Hospital—Consultants: Karl Erik Juul Jensen, Peiman Poornoroozy, Vagn Juhl Jensen, Grenå Hospital—Consultant: Jan Lindholt, Grindsted Hospital—Consultants: Anders Larsen, Vagn Berg, Herning Hospital—Consultants: Mogens Rørbæk, Holstebro Hospital—Consultants: Mads Mark, Erik Skoubo
References (39)
- et al.
Delay in diagnosis and treatment of symptomatic colorectal cancer
Lancet
(1979) - et al.
Colorectal cancer: incidence, delay in diagnosis and stage of disease
Eur J Cancer Clin Oncol
(1986) - et al.
Delay in treatment in carcinoma of colon and rectum
Lancet
(1965) - et al.
How important is rectal bleeding in the diagnosis of bowel cancer and polyps?
Lancet
(1986) - et al.
Abdominal pain in a 70-year-old Danish population. An epidemiological study of the prevalence and importance of abdominal pain
J Clin Epidemiol
(1992) - et al.
Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study
Lancet
(2002) - et al.
How does colorectal cancer present? Symptoms, duration, and clues to location
Am J Gastroenterol
(1999) - et al.
stimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden
Int J Cancer
(1993) - et al.
Estimates of the worldwide mortality from 25 cancers in 1990
Int. J Cancer
(1999) - et al.
Long-term trends in cancer mortality in the United States, 1930–1998
Cancer
(2003)
Screening for early colorectal cancer
World J Surg
Early diagnosis in colorectal cancer still no benefit?
Ann Chir
Patient's and doctor's delay in carcinoma of the colon and rectum
J Surg Oncol
Site emergency, and duration of symptoms in the prognosis of colorectal cancer
Dis Colon Rectum
Presentation, duration of symptoms and staging of colorectal carcinoma
Aust N Z J Surg
Duration of symptoms and prognosis of carcinoma of the colon and rectum
Surg Gynecol Obstet
The significance of the symptoms of carcinoma of the rectum
Surg Gynecol Obstet
Delay in the diagnosis and prognosis of carcinoma of the right colon
Br J Surg
Cited by (70)
The impact of COVID-19 pandemic on colorectal cancer patients at an NHS Foundation Trust hospital-A retrospective cohort study
2022, Annals of Medicine and SurgeryPrognosis and follow-up of CRC patients: Role of diagnostic and therapeutic delay
2021, Foundations of Colorectal CancerThe effect of diagnostic delay attributable to the healthcare system on the prognosis of colorectal cancer
2019, Gastroenterologia y HepatologiaConsequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
2016, Clinical Gastroenterology and HepatologyTime to first treatment after colonoscopy in patients suffering from colon or rectum cancer in France
2015, Cancer EpidemiologyCitation Excerpt :Due to the potential role of patient in term of treatment adherence, it is important that patients be involved in decisions related to their treatment and be given information that help them accepting the treatment of their illness.The time between diagnostic procedures and treatment is important in terms of preventing disease progression and limiting patient psychological distress. Some studies have found a significant relationship between delay in cancer care and prognosis [4–6]. Accordingly, cancer treatment delay has become a serious political and social issue requiring the production of regular indicators and of spatio-temporal comparisons.